Aspirin, cyclooxygenase inhibition and colorectal cancer

doi:10.4292/wjgpt.v5.i1.40

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12788)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

702

WORD

382

HTML

8474

Figures (1-2)

474

Tables (1-5)

234

Sum=10266

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1267

Download

1255

Sum=2522

Feb 6, 2014 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (62)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pharmacol Ther. Feb 6, 2014; 5(1): 40-49
Published online Feb 6, 2014. doi: 10.4292/wjgpt.v5.i1.40

Full Size Figure Download Figure

Figure 1 Balancing risk-benefits for the use of low dose aspirin. CRC: Colorectal cancer; NSAID: Nonsteroidal anti-inflammatory drug; CV: Cardiovascular; PPI: Proton pump inhibitor; ASA: Aspirin.

Citation: Sostres C, Gargallo CJ, Lanas A. Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastrointest Pharmacol Ther 2014; 5(1): 40-49
URL: https://www.wjgnet.com/2150-5349/full/v5/i1/40.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v5.i1.40